Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-25-000033
Filing Date
2025-05-06
Accepted
2025-05-06 16:20:44
Documents
85
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20250331.htm   iXBRL 10-Q 975892
2 EX-31.1 supn-10qxex311.htm EX-31.1 9646
3 EX-31.2 supn-10qxex312.htm EX-31.2 10008
4 EX-32.1 supn-10qxex321.htm EX-32.1 5134
5 EX-32.2 supn-10qxex322.htm EX-32.2 5151
11 CURRENT PORFOLIO supn-20250331_g1.jpg GRAPHIC 91137
  Complete submission text file 0001356576-25-000033.txt   6504976

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20250331.xsd EX-101.SCH 45119
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20250331_cal.xml EX-101.CAL 76870
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20250331_def.xml EX-101.DEF 170781
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20250331_lab.xml EX-101.LAB 603934
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20250331_pre.xml EX-101.PRE 403771
88 EXTRACTED XBRL INSTANCE DOCUMENT supn-20250331_htm.xml XML 904029
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 25917571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)